Strain identifier

BacDive ID: 14753

Type strain: No

Species: Streptococcus pyogenes

Strain Designation: Sv

Strain history: <- ATCC; ATCC 21059 <- S. Koshimura, Kanebo Ltd., Osaka, Japan; Sv (Streptococcus hemolyticus)

NCBI tax ID(s): 1314 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 9.2 (current version):
version 9:
version 8.1:
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 9.2 (current version)

General

@ref: 702

BacDive-ID: 14753

DSM-Number: 2071

keywords: Bacteria, microaerophile, mesophilic

description: Streptococcus pyogenes Sv is a microaerophile, mesophilic bacterium that was isolated from human isolate.

NCBI tax id

  • NCBI tax id: 1314
  • Matching level: species

strain history

  • @ref: 702
  • history: <- ATCC; ATCC 21059 <- S. Koshimura, Kanebo Ltd., Osaka, Japan; Sv (Streptococcus hemolyticus)

doi: 10.13145/bacdive14753.20241212.9.2

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/bacillota
  • domain: Bacteria
  • phylum: Bacillota
  • class: Bacilli
  • order: Lactobacillales
  • family: Streptococcaceae
  • genus: Streptococcus
  • species: Streptococcus pyogenes
  • full scientific name: Streptococcus pyogenes Rosenbach 1884 (Approved Lists 1980)

@ref: 702

domain: Bacteria

phylum: Firmicutes

class: Bacilli

order: Lactobacillales

family: Streptococcaceae

genus: Streptococcus

species: Streptococcus pyogenes

full scientific name: Streptococcus pyogenes Rosenbach 1884

strain designation: Sv

type strain: no

Morphology

colony morphology

  • @ref: 702
  • type of hemolysis: beta
  • hemolysis ability: 1

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
702COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)yeshttps://mediadive.dsmz.de/medium/693Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
702TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)yeshttps://mediadive.dsmz.de/medium/92Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water

culture temp

  • @ref: 702
  • growth: positive
  • type: growth
  • temperature: 37

Physiology and metabolism

oxygen tolerance

  • @ref: 702
  • oxygen tolerance: microaerophile

compound production

@refcompound
702streptolysin S
702anti-tumor agent

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
6838116199urea-hydrolysis
6838116443D-tagatose-builds acid from
6838117306maltose+builds acid from
6838128087glycogen-builds acid from
68381606565hippurate-hydrolysis
6838118333D-arabitol-builds acid from
6838140585alpha-cyclodextrin-builds acid from
6838130849L-arabinose-builds acid from
6838116634raffinose-builds acid from
6838117992sucrose+builds acid from
6838117716lactose+builds acid from
6838127082trehalose+builds acid from
6838130911sorbitol-builds acid from
6838116988D-ribose-builds acid from
6838129016arginine+hydrolysis
683816731melezitose-builds acid from
6838128053melibiose-builds acid from
6838127941pullulan+builds acid from
6838116899D-mannitol-builds acid from

enzymes

@refvalueactivityec
702catalase+1.11.1.6
702cytochrome-c oxidase-1.9.3.1
68381urease-3.5.1.5
68381beta-mannosidase-3.2.1.25
68381beta-galactosidase-3.2.1.23
68381Alanyl-Phenylalanyl-Proline arylamidase+
68381alkaline phosphatase+3.1.3.1
68381beta-glucuronidase-3.2.1.31
68381arginine dihydrolase+3.5.3.6
68381beta-glucosidase-3.2.1.21
68381N-acetyl-beta-glucosaminidase-3.2.1.52
68381pyrrolidonyl arylamidase+3.4.19.3
68381alpha-galactosidase-3.2.1.22

API rID32STR

@refADH Argbeta GLUbeta GARbeta GURalpha GALPALRIBMANSORLACTRERAFSACLARADARLCDEXVPAPPAbeta GALPyrAbeta NAGGTAHIPGLYGPULMALMELMLZMbeta DGTAGbeta MANURE
702+----+---++-+----+-+----++--+---
702+----+---++-+----+-+-+--++--+/----
702+----+---++-+---++-+-+--++--+---

Isolation, sampling and environmental information

isolation

  • @ref: 702
  • sample type: human isolate

isolation source categories

  • Cat1: #Host
  • Cat2: #Human

Safety information

risk assessment

  • @ref: 702
  • biosafety level: 2
  • biosafety level comment: Risk group (German classification)

External links

@ref: 702

culture collection no.: DSM 2071, ATCC 21059

straininfo link

  • @ref: 83870
  • straininfo: 37257

literature

topicPubmed-IDtitleauthorsjournalyearmeshtopic2DOI
Metabolism11545275Lactobacillus casei acquires the binding activity to fibronectin by the expression of the fibronectin binding domain of Streptococcus pyogenes on the cell surface.Kushiro A, Takahashi T, Asahara T, Tsuji H, Nomoto K, Morotomi MJ Mol Microbiol Biotechnol2001*Adhesins, Bacterial, Amino Acid Sequence, Animals, Bacterial Adhesion, Bacterial Proteins/chemistry/genetics/metabolism, Base Sequence, Binding Sites/genetics, Carrier Proteins/chemistry/genetics/metabolism, Cell Line, Cell Membrane/metabolism, DNA, Bacterial/genetics, Fibrinogen/metabolism, Fibronectins/*metabolism, Lactobacillus casei/genetics/*metabolism/ultrastructure, Metalloendopeptidases/chemistry/genetics/metabolism, Mice, Microscopy, Immunoelectron, Molecular Sequence Data, Phenotype, Protein Structure, Tertiary, Recombinant Fusion Proteins/chemistry/genetics/metabolism, Staphylococcus aureus/genetics/metabolism, Streptococcus pyogenes/genetics/*metabolismGenetics
Pathogenicity16226831Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJFood Chem Toxicol2005Acne Vulgaris/*drug therapy/microbiology, Anti-Bacterial Agents/*pharmacology/therapeutic use, Bacteriocins/*pharmacology/therapeutic use, Humans, Lactococcus/*metabolism, Microbial Sensitivity Tests, Propionibacterium acnes/*drug effects, Staphylococcus/*drug effectsMetabolism10.1016/j.fct.2005.08.030
Pathogenicity16793484Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJFood Chem Toxicol2006Adult, Allantois/drug effects, Animals, Bacteriocins/isolation & purification/*pharmacology/toxicity, Chick Embryo, Cosmetics, Dermatitis/drug therapy/*microbiology, Dermatitis, Irritant/etiology, Female, Fibroblasts/drug effects, Gram-Positive Bacterial Infections/drug therapy/*microbiology, Humans, Lactococcus/*metabolism, Microbial Sensitivity Tests, Propionibacterium acnes/drug effects, Skin Diseases, Infectious/drug therapy/*microbiology, Skin Tests, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Streptococcus pyogenes/drug effectsEnzymology10.1016/j.fct.2005.08.008

Reference

@idauthorscataloguedoi/urltitle
702Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 2071)https://www.dsmz.de/collection/catalogue/details/culture/DSM-2071
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
68381Automatically annotated from API rID32STR
83870Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID37257.1StrainInfo: A central database for resolving microbial strain identifiers